Biogen Says Physician Debate About Aduhelm More ‘Pervasive’ Than Anticipated

Lilly Optimistic About Donanemab Opportunity At Citi Event

 
• By Mandy Jackson
Conflicting people surrounded by spectators
Biogen is moving forward with publications to reduce doctor debates about Aduhelm • Source: Alamy

More from New Products

More from Scrip